Journal
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 6, Pages 2269-2279Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1502486
Keywords
-
Categories
Funding
- Japan Society for the Promotion of Science [22390098]
- National Center for Global Health and Medicine [21-111, 22-303]
- Grants-in-Aid for Scientific Research [22390098, 16K19102, 15H04503, 15K21649] Funding Source: KAKEN
Ask authors/readers for more resources
ESET/SETDB1, one of the major histone methyltransferases, catalyzes histone 3 lysine 9 (H3K9) trimethylation. ESET is critical for suppressing expression of retroviral elements in embryonic stem cells; however, its role in the immune system is not known. We found that thymocyte-specific deletion of ESET caused impaired T cell development, with CD8 lineage cells being most severely affected. Increased apoptosis of CD8 single-positive cells was observed, and TCR-induced ERK activation was severely inhibited in ESET-/- thymocytes. Genome-wide comprehensive analysis of mRNA expression and H3K9 trimethylation revealed that ESET regulates expression of numerous genes in thymocytes. Among them, Fc gamma RIIB, whose signaling can inhibit ERK activation, was strongly and ectopically expressed in ESET-/- thymocytes. Indeed, genetic depletion of Fc gamma RIIB in ESET-/- thymocytes rescued impaired ERK activation and partially restored defective positive selection in ESET (-/-) mice. Therefore, impaired T cell development in ESET-/- mice is partly due to the aberrant expression of Fc gamma RIIB. Collectively, to our knowledge, we identify ESET as the first trimethylated H3K9 histone methyltransferase playing a crucial role in T cell development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available